PortalPublikationenSecond-generation transapical valves: the Medtronic Engager ...

Second-generation transapical valves: the Medtronic Engager system

Standard

Second-generation transapical valves: the Medtronic Engager system. / Sündermann, Simon H; Holzhey, David; Bleiziffer, Sabine; Treede, Hendrik; Jacobs, Stephan; Falk, Volkmar.

in: Multimedia manual of cardiothoracic surgery : MMCTS, Jahrgang 2014, 2014, S. mmu001.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Sündermann, SH, Holzhey, D, Bleiziffer, S, Treede, H, Jacobs, S & Falk, V 2014, 'Second-generation transapical valves: the Medtronic Engager system', Multimedia manual of cardiothoracic surgery : MMCTS, Jg. 2014, S. mmu001. https://doi.org/10.1093/mmcts/mmu001

APA

Sündermann, S. H., Holzhey, D., Bleiziffer, S., Treede, H., Jacobs, S., & Falk, V. (2014). Second-generation transapical valves: the Medtronic Engager system. Multimedia manual of cardiothoracic surgery : MMCTS, 2014, mmu001. https://doi.org/10.1093/mmcts/mmu001

Vancouver

Sündermann SH, Holzhey D, Bleiziffer S, Treede H, Jacobs S, Falk V. Second-generation transapical valves: the Medtronic Engager system. Multimedia manual of cardiothoracic surgery : MMCTS. 2014;2014:mmu001. https://doi.org/10.1093/mmcts/mmu001

Bibtex

@article{fe8bfa6118324bcf89d41b7b27f0dba6,
title = "Second-generation transapical valves: the Medtronic Engager system",
abstract = "The Medtronic Engager aortic valve system is a second-generation transcatheter aortic valve implantation bioprosthesis combined with a delivery system designed for over-the-wire transapical implantation of the valve. The self-expandable stent has control arms to be placed into the native aortic sinuses to achieve correct positioning of the bioprosthesis in a predefined height. The purpose of the lower skirt is to reduce paravalvular leakage. A three-leaflet, bovine pericardium valve is mounted on the stent. The implantation is facilitated by the control arms and rotational positioning of the commissural posts. A multicentre feasibility study showed promising results. The results from the following European pivotal trial led to CE mark approval in 2013. Here, we describe technical details of the device and its implantation technique and highlight special steps of the procedure. ",
keywords = "Angiography/methods, Aortic Valve/surgery, Aortic Valve Stenosis/physiopathology, Bioprosthesis, Cardiac Catheterization/methods, Heart Valve Prosthesis, Humans, Intraoperative Care/methods, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure/etiology, Prosthesis Fitting/methods, Severity of Illness Index, Stents, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome",
author = "S{\"u}ndermann, {Simon H} and David Holzhey and Sabine Bleiziffer and Hendrik Treede and Stephan Jacobs and Volkmar Falk",
year = "2014",
doi = "10.1093/mmcts/mmu001",
language = "English",
volume = "2014",
pages = "mmu001",

}

RIS

TY - JOUR

T1 - Second-generation transapical valves: the Medtronic Engager system

AU - Sündermann, Simon H

AU - Holzhey, David

AU - Bleiziffer, Sabine

AU - Treede, Hendrik

AU - Jacobs, Stephan

AU - Falk, Volkmar

PY - 2014

Y1 - 2014

N2 - The Medtronic Engager aortic valve system is a second-generation transcatheter aortic valve implantation bioprosthesis combined with a delivery system designed for over-the-wire transapical implantation of the valve. The self-expandable stent has control arms to be placed into the native aortic sinuses to achieve correct positioning of the bioprosthesis in a predefined height. The purpose of the lower skirt is to reduce paravalvular leakage. A three-leaflet, bovine pericardium valve is mounted on the stent. The implantation is facilitated by the control arms and rotational positioning of the commissural posts. A multicentre feasibility study showed promising results. The results from the following European pivotal trial led to CE mark approval in 2013. Here, we describe technical details of the device and its implantation technique and highlight special steps of the procedure.

AB - The Medtronic Engager aortic valve system is a second-generation transcatheter aortic valve implantation bioprosthesis combined with a delivery system designed for over-the-wire transapical implantation of the valve. The self-expandable stent has control arms to be placed into the native aortic sinuses to achieve correct positioning of the bioprosthesis in a predefined height. The purpose of the lower skirt is to reduce paravalvular leakage. A three-leaflet, bovine pericardium valve is mounted on the stent. The implantation is facilitated by the control arms and rotational positioning of the commissural posts. A multicentre feasibility study showed promising results. The results from the following European pivotal trial led to CE mark approval in 2013. Here, we describe technical details of the device and its implantation technique and highlight special steps of the procedure.

KW - Angiography/methods

KW - Aortic Valve/surgery

KW - Aortic Valve Stenosis/physiopathology

KW - Bioprosthesis

KW - Cardiac Catheterization/methods

KW - Heart Valve Prosthesis

KW - Humans

KW - Intraoperative Care/methods

KW - Postoperative Complications/etiology

KW - Prosthesis Design

KW - Prosthesis Failure/etiology

KW - Prosthesis Fitting/methods

KW - Severity of Illness Index

KW - Stents

KW - Transcatheter Aortic Valve Replacement/adverse effects

KW - Treatment Outcome

U2 - 10.1093/mmcts/mmu001

DO - 10.1093/mmcts/mmu001

M3 - SCORING: Journal article

C2 - 24568935

VL - 2014

SP - mmu001

ER -